Back
Cue Biopharma Stock Price Chart
Sponsored
CUE
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- The current trend is moderately bearish and CUE is experiencing slight selling pressure.
Cue Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.68 | Sell |
20-day SMA: | 1.62 | Sell |
50-day SMA: | 1.12 | Buy |
200-day SMA: | 1.41 | Buy |
8-day EMA: | 1.62 | Sell |
20-day EMA: | 1.54 | Sell |
50-day EMA: | 1.29 | Buy |
200-day EMA: | 1.47 | Buy |
Cue Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 50.94 | Buy |
Chaikin Money Flow: | -441294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.31 - 1.75) | Sell |
Bollinger Bands (100): | (0.58 - 1.36) | Buy |
Cue Biopharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cue Biopharma Stock
Is Cue Biopharma Stock a Buy?
- Cue Biopharma share price is 1.50 while CUE 8-day simple moving average is 1.68, which is a Sell signal.
- The stock price of CUE is 1.50 while Cue Biopharma 20-day SMA is 1.62, which makes it a Sell.
- Cue Biopharma 50-day simple moving average is 1.12 while CUE share price is 1.50, making it a Buy technically.
- CUE stock price is 1.50 and Cue Biopharma 200-day simple moving average is 1.41, creating a Buy signal.
CUE Technical Analysis vs Fundamental Analysis
Buy
54
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy or a Sell?
-
Cue Biopharma stock is rated a Buy
The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Cue Biopharma Stock Info
Market Cap:
90.31M
Price in USD:
1.50
Share Volume:
1.32M
Cue Biopharma 52-Week Range
52-Week High:
3.25
52-Week Low:
0.45
Buy
54
Cue Biopharma (CUE)
is a Buy
Cue Biopharma Share Price Forecast
-
What is the Cue Biopharma stock price today?
The Cue Biopharma stock price is 1.50 USD today. -
Will CUE stock go up or go down?
Cue Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Cue Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cue Biopharma is not overvalued.
Is Cue Biopharma Stock a Buy?
- Cue Biopharma share price is 1.50 while CUE 8-day exponential moving average is 1.62, which is a Sell signal.
- The stock price of CUE is 1.50 while Cue Biopharma 20-day EMA is 1.54, which makes it a Sell.
- Cue Biopharma 50-day exponential moving average is 1.29 while CUE share price is 1.50, making it a Buy technically.
- CUE stock price is 1.50 and Cue Biopharma 200-day simple moving average is 1.47, creating a Buy signal.
Fundamental Analysis of Cue Biopharma
Is Cue Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
Technical Analysis of Cue Biopharma
Should I short Cue Biopharma stock?
- CUE Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Cue Biopharma is a Buy
- Cue Biopharma Relative Strength Index (RSI) is 50.94, which suggest Cue Biopharma is overbought
- The Bollinger Bands (25) for Cue Biopharma is (1.31 - 1.75), which suggest Cue Biopharma is a Buy
- The Bollinger Bands (100) for Cue Biopharma is (0.58 - 1.36), which suggest Cue Biopharma is a Buy
* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.